These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23989096)

  • 41. [Drug treatment of alcohol withdrawal].
    Helland A; Skjøtskift S
    Tidsskr Nor Laegeforen; 2008 May; 128(10):1182-4. PubMed ID: 18480869
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacotherapy of alcohol-withdrawal syndrome in hospitalised patients. Clinical and methodological aspects.
    Busch H; Frings A
    Pharmacopsychiatry; 1988 Sep; 21(5):232-7. PubMed ID: 3067245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients.
    Hodges B; Mazur JE
    Pharmacotherapy; 2004 Nov; 24(11):1578-85. PubMed ID: 15537562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of high dose benzodiazepines in alcohol and sedative withdrawal delirium.
    Kunkel EJ; Rodgers C; DeMaria PA; Holleran D; Zaimes J; Gray C; Zager R; Hall SM; Field HL
    Gen Hosp Psychiatry; 1997 Jul; 19(4):286-93. PubMed ID: 9327258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacological treatment of substance dependence from a neuroscientific perspective (II): alcohol, benzodiazepines and nicotine].
    Haro G; Cervera G; Martinez-Raga J; Pérez-Gálvez B; Fernandez-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(5):284-98. PubMed ID: 14557953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically Ill neonates, children and adults: A systematic review of clinical studies.
    Duceppe MA; Perreault MM; Frenette AJ; Burry LD; Rico P; Lavoie A; Gélinas C; Mehta S; Dagenais M; Williamson DR
    J Clin Pharm Ther; 2019 Apr; 44(2):148-156. PubMed ID: 30569508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapy.
    Kox M; Hoedemaekers AW; Pickkers P; van der Hoeven JG; Pompe JC
    Crit Care Med; 2007 Oct; 35(10):2468-9; author reply 2469. PubMed ID: 17885405
    [No Abstract]   [Full Text] [Related]  

  • 48. [The alcohol withdrawal syndrome. Diagnosis and treatment].
    Bovim G; Fauske S; Strandjord RE
    Tidsskr Nor Laegeforen; 1987 Jan; 107(3):242-4. PubMed ID: 3824310
    [No Abstract]   [Full Text] [Related]  

  • 49. Nicotine replacement therapy in critically ill patients: a prospective observational cohort study.
    Cartin-Ceba R; Warner DO; Hays JT; Afessa B
    Crit Care Med; 2011 Jul; 39(7):1635-40. PubMed ID: 21494111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome.
    Barrons R; Roberts N
    J Clin Pharm Ther; 2010 Apr; 35(2):153-67. PubMed ID: 20456734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Organic cerebral reactions in alcoholism: psychobiological aspects of treatment.
    Hemmingsen R; Kramp P; Rafaelsen OJ
    Subst Alcohol Actions Misuse; 1983; 4(2-3):225-34. PubMed ID: 6139882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition and treatment of the alcohol withdrawal syndrome.
    Leroy JB
    Prim Care; 1979 Sep; 6(3):529-39. PubMed ID: 392576
    [No Abstract]   [Full Text] [Related]  

  • 53. [Diagnostics and therapy of alcohol withdrawal syndrome: focus on delirium tremens and withdrawal seizure].
    Lutz UC; Batra A
    Psychiatr Prax; 2010 Sep; 37(6):271-8. PubMed ID: 20803410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of phenobarbital-adjunct versus benzodiazepine-only approach for alcohol withdrawal syndrome in the ED.
    Sullivan SM; Dewey BN; Jarrell DH; Vadiei N; Patanwala AE
    Am J Emerg Med; 2019 Jul; 37(7):1313-1316. PubMed ID: 30414743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment and treatment of the withdrawal syndrome in paediatric intensive care units: Systematic review.
    Ávila-Alzate JA; Gómez-Salgado J; Romero-Martín M; Martínez-Isasi S; Navarro-Abal Y; Fernández-García D
    Medicine (Baltimore); 2020 Jan; 99(5):e18502. PubMed ID: 32000360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trends in the management of alcohol withdrawal syndrome.
    Newman JP; Terris DJ; Moore M
    Laryngoscope; 1995 Jan; 105(1):1-7. PubMed ID: 7837904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dexmedetomidine in the treatment of acute alcohol withdrawal delirium].
    Gerresheim G; Brederlau J; Schwemmer U
    Anaesthesist; 2016 Jul; 65(7):525-31. PubMed ID: 27287404
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative management of patients with alcohol, tobacco and drug dependency.
    Kork F; Neumann T; Spies C
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):384-90. PubMed ID: 20404723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Front-Loaded Versus Low-Intermittent Phenobarbital Dosing for Benzodiazepine-Resistant Severe Alcohol Withdrawal Syndrome.
    Shah P; Stegner-Smith KL; Rachid M; Hanif T; Dodd KW
    J Med Toxicol; 2022 Jul; 18(3):198-204. PubMed ID: 35668289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacopsychiatric guidelines for treatment of alcohol withdrawal syndrome].
    Schröder-Rosenstock K; Busch H
    Z Arztl Fortbild (Jena); 1996 Jun; 90(4):301-6. PubMed ID: 8928529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.